Organization Profile

You just read:

Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia

News provided by

Aptose Biosciences Inc.

Jun 02, 2015, 14:00 ET